News Releases

Date Title
01/06/2014 Summary ToggleEnanta Pharmaceuticals to Present at the 32nd Annual J.P. Morgan Healthcare Conference
12/10/2013 Summary ToggleEnanta Pharmaceuticals Announces 96 Percent SVR12 in Treatment Experienced Genotype 1 Hepatitis C Patients in SAPPHIRE-II Study
11/25/2013 Summary ToggleEnanta Pharmaceuticals to Present at the Deutsche Bank 2013 BioFest
11/25/2013 Summary ToggleEnanta Pharmaceuticals Reports Financial Results for the Fiscal Fourth Quarter and Year Ended September 30, 2013
11/25/2013 Summary ToggleEnanta Pharmaceuticals Announces the Appointment of Bruce L.A. Carter, Ph.D. to Board of Directors
11/18/2013 Summary ToggleEnanta Pharmaceuticals Announces 96 Percent SVR12 in SAPPHIRE-I Study
11/15/2013 Summary ToggleEnanta Pharmaceuticals to Host Conference Call to Discuss Financial Results for the Fiscal Fourth Quarter and Year Ended September 30, 2013
11/06/2013 Summary ToggleEnanta Pharmaceuticals to Present at the 2013 Credit Suisse Healthcare Conference
11/03/2013 Summary ToggleNew GT-1b Data from ABT-450 Containing Regimen Being Presented at The Liver Meeting
10/01/2013 Summary ToggleEnanta Announces New Data on ABT-450 Regimens to be Presented at The Liver Meeting (AASLD)